Associated Papers
Impact of chromosomal aberrations detected by chromosome banding analysis in symptomatic Waldenström's macroglobulinemia.
Ito K et al.
Annals of Hematology, 2025
39412659 (PubMed )
Supplement: 277_2024_6041_MOESM5_ESM.docx
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS et al.
Blood Advances, 2024
38315878 (PubMed )
Supplement: BLOODA_ADV-2023-010906-mmc1.pdf
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.
Xu H et al.
Cellular & Molecular Immunology, 2023
Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.
Milanesi S et al.
International Journal of Molecular Sciences, 2020
Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing.
Shin DW et al.
Clinical Lymphoma, Myeloma & Leukemia, 2019
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX et al.
Annals of Hematology, 2017
Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
Poulain S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2016
Select a paper to view details